Relationship of apoptosis and its regulating protein Bcl-2,Bax expression to pathogenesis of endometriosis.

In: Chinese Journal of Birth Health & Heredity · 2007 · W2376336681
article OA: closed CC0
View on OpenAlex

Abstract

Objective:To investigate the apoptosis regulating protein Bcl-2 and Bax expression in endometrium with non endometriosis(control),eutopic endometrium and ectopic endometrium with EMS in abdominal wall endometriosis,ovarian endometriosis and adenomyosis respectively.Methods:The expressions of Bcl-2,Bax of these samples were investigated by immunohistochemical assay.Cell apoptosis in each endometrial tissures was determined by flow cytometry.Results :The expression of Bcl-2 or Bax in the eutopic endometrium was the same as the normal endometrium,showing obvious cyclic changes.An increased expression of Bcl-2 and Bax was found in proliferative eutopic endometrium of healthy controls than secretory endometrium(P0.05).The Bcl-2 and Bax expression in adenomyosis and in abdominal wall endometriosis was not the cyclic change.Less expression of Bcl-2 and Bax was found in the ovarian endometriosis.There was significant difference of apoptosis rate among control,eutopic endometrium and ectopic endometrium(P0.05).Conclusions:①The Bcl-2 and Bax cyclic change may play an important role in the proliferation and physiologic death of normal and eutopic endometrial glandular epithelial cells.②Bcl-2 may play an important role in forming adenomyosis and abdominal wall endometriosis.③Bcl-2 may be the cause of forming chocolate cyst by prompting apoptosis.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK